Biosimilars A New Generation of Biologics /
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular co...
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Language: | English |
| Published: |
Paris :
Springer Paris : Imprint: Springer,
2013.
|
| Edition: | 1st ed. 2013. |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-2-8178-0336-4 |